Management of Malignant Pleural Effusions in US Veterans: A Retrospective Review

被引:1
|
作者
Mohs, Zachary [1 ]
DeVillers, Megan [1 ]
Ziegler, Stephanie [1 ]
Basson, Marc D. [2 ,4 ]
Newman, William [1 ,3 ]
机构
[1] UND, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND USA
[2] UND, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND USA
[3] Fargo Vet Affairs Med Ctr, Dept Internal Med, Fargo, ND USA
[4] UND, Sch Med & Hlth Sci, Dept Surg, 1301 N Columbia Rd, Grand Forks, ND 58203 USA
关键词
talc pleurodesis; indwelling pleural catheter; malignant pleural effusion; TALC PLEURODESIS; CATHETER; DYSPNEA;
D O I
10.5761/atcs.oa.22-00124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare malignant pleural effusion (MPE) treatment outcomes and compli-cations among patients receiving indwelling pleural catheter (IPC), talc pleurodesis (TPS), or dual therapy. Outcomes were determined by measuring length of stay (LOS) and post-procedure dyspnea scores. Complications were measured by comparing intervention failures and adverse events.Methods: The Veterans Affairs' Corporate Data Warehouse was utilized to retrospectively review the charts of 314 MPE subjects. Dyspnea scores were estimated by researchers and LOS was determined by adding the duration of stay for all admissions post procedure. Complications were recorded through chart review.Results: IPC exhibited higher failure rates than the other approaches 1 year post inter-vention. Pneumonia/chest infection rate and lung entrapment were also more prevalent. There was no significant difference in dyspnea rates. LOS illustrated a significant differ-ence between groups, with talc patients spending a median of 7 days in the hospital immediately post procedure, while IPC and IPC + TPS patients spent a median of 3 and 2 days, respectively.Conclusion: Patients receiving IPC or combination treatment spend fewer days in the hospital than TPS patients. However, IPC appears to be associated with more adverse events and higher long-term failure rates than other management strategies.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [1] A retrospective review of the palliative surgical management of malignant pleural effusions
    Bell, David
    Wright, Gavin
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2014, 4 (02) : 161 - 166
  • [2] A retrospective review of management of malignant pleural effusions with indwelling pleural catheters in Dorset
    Punwani, R.
    Isola, P.
    Graves, J.
    Edwards, D.
    Grey, A.
    Vythilingam, S.
    LUNG CANCER, 2020, 139 : S83 - S83
  • [3] Management of Malignant Pleural Effusions
    Shafiq, Majid
    Feller-Kopman, David
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 259 - +
  • [4] Management of malignant pleural effusions
    Thomas, Rajesh
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 63 - 63
  • [5] ON THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    DEVRIES, BC
    BITRAN, JD
    CHEST, 1994, 105 (01) : 1 - 2
  • [6] Management of malignant pleural effusions
    Rodriguez-Panadero, Francisco
    Romero-Romero, Beatriz
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (04) : 269 - 273
  • [7] Management of malignant pleural effusions
    Dipper, Alexandra
    Bhatnagar, Rahul
    Maskell, Nick
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 341 - 345
  • [8] Management of malignant pleural effusions
    David Hsia
    Ali I. Musani
    Current Respiratory Care Reports, 2012, 1 (2): : 73 - 81
  • [9] MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    RUCKDESCHEL, JC
    SEMINARS IN ONCOLOGY, 1995, 22 (02) : 58 - 63
  • [10] Management of malignant pleural effusions
    Bennett, R
    Maskell, N
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 296 - 300